Recent Finacing
Recent Raise
Arno Therapeutics is a clinical-stage biopharmaceutical company developing oncology drugs, advancing AR-12 (oral PDK1 inhibitor), AR-67 (Topoisomerase I inhibitor), and AR-42 (oral HDAC inhibitor) in multiple cancer trials.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors